Education
About Us
Working with TipRanks
Follow Us
PharmaNutra SpA (IT:PHN)
:PHN
Total Valuation
PharmaNutra SpA has a market cap or net worth of €444.84M. The enterprise value is €440.42M.
Market Cap€444.84M
Enterprise Value€440.42M
Share Statistics
PharmaNutra SpA has 9,680,977 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding9,680,977
Owned by Insiders34.54%
Owned by Institutions―
Financial Efficiency
PharmaNutra SpA’s return on equity (ROE) is 0.27 and return on invested capital (ROIC) is 17.58%.
Return on Equity (ROE)0.27
Return on Assets (ROA)0.14
Return on Invested Capital (ROIC)17.58%
Return on Capital Employed (ROCE)0.30
Revenue Per Employee989.73K
Profits Per Employee140.27K
Employee Count118
Asset Turnover0.99
Inventory Turnover4.90
Valuation Ratios
The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio26.9
PS Ratio0.00
PB Ratio6.93
Price to Fair Value8.41
Price to FCF21.28
Price to Operating Cash Flow17.98
PEG Ratio-23.41
Income Statement
In the last 12 months, PharmaNutra SpA had revenue of 116.79M and earned 16.61M in profits. Earnings per share was 1.73.
Revenue116.79M
Gross Profit82.79M
Operating Income27.37M
Pretax Income27.16M
Net Income16.61M
EBITDA32.01M
Earnings Per Share (EPS)1.73
Cash Flow
In the last 12 months, operating cash flow was 24.85M and capital expenditures -4.16M, giving a free cash flow of 20.69M billion.
Operating Cash Flow24.85M
Free Cash Flow20.69M
Free Cash Flow per Share2.14
Dividends & Yields
PharmaNutra SpA pays an annual dividend of €1, resulting in a dividend yield of 2.18%
Dividend Per Share€1
Dividend Yield2.18%
Payout Ratio59.17%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.50
52-Week Price Change-2.09%
50-Day Moving Average48.51
200-Day Moving Average51.47
Relative Strength Index (RSI)38.79
Average Volume (3m)7.61K
Important Dates
PharmaNutra SpA upcoming earnings date is Sep 8, 2025, TBA (Confirmed).
Last Earnings DateMay 12, 2025
Next Earnings DateSep 8, 2025
Ex-Dividend DateMay 05, 2025
Financial Position
PharmaNutra SpA as a current ratio of 2.38, with Debt / Equity ratio of 37.32%
Current Ratio2.38
Quick Ratio2.12
Debt to Market Cap0.04
Net Debt to EBITDA0.27
Interest Coverage Ratio25.78
Taxes
In the past 12 months, PharmaNutra SpA has paid 10.61M in taxes.
Income Tax10.61M
Effective Tax Rate0.39
Enterprise Valuation
PharmaNutra SpA EV to EBITDA ratio is 16.60, with an EV/FCF ratio of 32.70.
EV to Sales4.55
EV to EBITDA16.60
EV to Free Cash Flow32.70
EV to Operating Cash Flow25.92
Balance Sheet
PharmaNutra SpA has €30.76M in cash and marketable securities with €24.05M in debt, giving a net cash position of -€6.71M billion.
Cash & Marketable Securities€30.76M
Total Debt€24.05M
Net Cash-€6.71M
Net Cash Per Share-€0.69
Tangible Book Value Per Share€4.05
Margins
Gross margin is 66.81%, with operating margin of 23.44%, and net profit margin of 14.22%.
Gross Margin66.81%
Operating Margin23.44%
Pretax Margin23.26%
Net Profit Margin14.22%
EBITDA Margin27.41%
EBIT Margin24.17%
Analyst Forecast
The average price target for PharmaNutra SpA is €79.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target€79.00
Price Target Upside71.93% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast17.78%
EPS Growth Forecast63.72%